Cases & Deals

TxCell completes IPO on regulated market of Euronext in Paris

Clients TxCell SA

Jones Day advised TxCell SA, a biotech company specializing in innovative, personalized cell-based immunotherapies, in connection with its €16.2 million (US$22.4 million) initial public offering of Ordinary Shares on the regulated market of Euronext in Paris. Oddo & Cie and Société Générale acted as joint book-running managers.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.